The FDA on Thursday approved Teva Pharmaceuticals' generic version of the drug, dealing a blow to branded EpiPen-maker Mylan. Mylan saw an approximately 63% drop in EpiPen sales between 2017 and ...
Teva has a mixed record of launching complex generics on time, but it has also shown success in certain drugs, including having the only generic version of EpiPen available in the US. We expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback